Investors
Interim Report to 30 September 2015 is now available to view via the following link. The PDF report will download automatically when clicked.
151229-AFT-FY16-Interim-Report.pdf
May 26, 2025
AFT Pharmaceuticals (NZX:AFT, ASX:AFP) today announces it has extended its US Maxigesic® licensing agreement with Hikma Pharmaceuticals….
May 1, 2024
We are delighted to announce our partnership with Brazil’s Halex Istar, and to be exclusively responsible for distributing its Maxigesic IV in Brazi…
April 24, 2024
AFT collaborate with Massey Ventures and Gilles McIndoe to begin the development of a topical treatment for keloid and hypertrophic scarring….